Paper16039986
Extensive modulation of a set of microRNAs in primary glioblastoma.
Ciafrè SA and 9 others. Biochem Biophys Res Commun, 2005. Cited by 871 papers, by iCite.
Cite this record
ConductScience Library. Extensive modulation of a set of microRNAs in primary glioblastoma. Papers, record 16039986. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/16039986
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Publication types
- Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
- PubMed
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Brain | Major topic |
| Gene Expression Regulation, Neoplastic | Major topic |
| Glioblastoma | Major topic |
| MicroRNAs | Major topic |
| Cell Differentiation | |
| Cell Line, Tumor | |
| Female | |
| Humans | |
| Male | |
| Reference Values |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA083698 | NCI NIH HHS | United States | R01CA083698 | PubMed and NIH | NIH RePORTER |
| P01CA76259 | NCI NIH HHS | United States | P01CA076259 | PubMed and NIH | NIH RePORTER |
| P01CA81534 | NCI NIH HHS | United States | P01CA081534 | PubMed and NIH | NIH RePORTER |
Cited by533
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 871 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42122149 | Targeting Glioblastoma Stem Cells: Therapeutic Strategies and Clinical Perspectives. | Cancers (Basel) | 2026 | https://conductscience.org/library/papers/42122149 | PubMed |
| 41670044 | microRNA involvement in human cancer. | Carcinogenesis | 2025 | https://conductscience.org/library/papers/41670044 | PubMed |
| 41590784 | Nanotherapy Targeting miR-10b Improves Survival in Orthotopic Glioblastoma Models. | J Funct Biomater | 2025 | https://conductscience.org/library/papers/41590784 | PubMed |
| 41479042 | A Comprehensive Guide on Epigenetics' Precision Role in Uncommon "Rare" Cancers' Biology and Treatment Frontiers. | Subcell Biochem | 2026 | https://conductscience.org/library/papers/41479042 | PubMed |
| 41331452 | Extracellular vesicle-derived miR21 of non-tumoral origin as early diagnostic marker of glioma. | J Neuroinflammation | 2025 | https://conductscience.org/library/papers/41331452 | PubMed |
| 40860328 | Molecular profiling of neuronal extracellular vesicles reveals brain tissue specific signals. | Exposome | 2025 | https://conductscience.org/library/papers/40860328 | PubMed |
| 40544306 | A novel approach to enhance glioblastoma multiforme treatment efficacy: non-coding RNA targeted therapy and adjuvant approaches. | Clin Epigenetics | 2025 | https://conductscience.org/library/papers/40544306 | PubMed |
| 40443744 | Exosomes in Glioma: Diagnostic and Therapeutic Potentials. | Adv Oncol | 2025 | https://conductscience.org/library/papers/40443744 | PubMed |
| 40381097 | miR-128-3p Reduces Proliferation and Immune Escape in Acute Myeloid Leukemia Through Targeted Regulation of ZEB1. | Appl Biochem Biotechnol | 2025 | https://conductscience.org/library/papers/40381097 | PubMed |
| 39574474 | hsa-miR-181a-5p inhibits glioblastoma development via the MAPK pathway: in-silico and in-vitro study. | Oncol Res | 2024 | https://conductscience.org/library/papers/39574474 | PubMed |
| 39563028 | CRISPR targeting of mmu-miR-21a through a single adeno-associated virus vector prolongs survival of glioblastoma-bearing mice. | Mol Ther | 2025 | https://conductscience.org/library/papers/39563028 | PubMed |
| 39334350 | Exploring the clinical implications and applications of exosomal miRNAs in gliomas: a comprehensive study. | Cancer Cell Int | 2024 | https://conductscience.org/library/papers/39334350 | PubMed |
| 39227405 | A method for miRNA diffusion association prediction using machine learning decoding of multi-level heterogeneous graph Transformer encoded representations. | Sci Rep | 2024 | https://conductscience.org/library/papers/39227405 | PubMed |
| 39180605 | Genomic, epigenomic and transcriptomic landscape of glioblastoma. | Metab Brain Dis | 2024 | https://conductscience.org/library/papers/39180605 | PubMed |
| 39063215 | Circulating Liquid Biopsy Biomarkers in Glioblastoma: Advances and Challenges. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/39063215 | PubMed |
| 38893174 | Restricting Colorectal Cancer Cell Metabolism with Metformin: An Integrated Transcriptomics Study. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38893174 | PubMed |
| 38892054 | How MicroRNAs Command the Battle against Cancer. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38892054 | PubMed |
| 38609422 | MiRNAs from the Dlk1-Dio3 locus and miR-224/452 cluster contribute to glioblastoma tumor heterogeneity. | Sci Rep | 2024 | https://conductscience.org/library/papers/38609422 | PubMed |
| 38525735 | miR-125 in Breast Cancer Etiopathogenesis: An Emerging Role as a Biomarker in Differential Diagnosis, Regenerative Medicine, and the Challenges of Personalized Medicine. | Noncoding RNA | 2024 | https://conductscience.org/library/papers/38525735 | PubMed |
| 38473776 | Glioblastoma Therapy: Past, Present and Future. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38473776 | PubMed |
Genes6
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| MIR181A1 | 406995 | PubTator's text mining | https://conductscience.org/library/genes/406995 | NCBI Gene |
| MIR181A2 | 406954 | PubTator's text mining | https://conductscience.org/library/genes/406954 | NCBI Gene |
| MIR181B1 | 406955 | PubTator's text mining | https://conductscience.org/library/genes/406955 | NCBI Gene |
| MIR181B2 | 406956 | PubTator's text mining | https://conductscience.org/library/genes/406956 | NCBI Gene |
| MIR181C | 406957 | PubTator's text mining | https://conductscience.org/library/genes/406957 | NCBI Gene |
| MIR221 | 407006 | PubTator's text mining | https://conductscience.org/library/genes/407006 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/16039986
GET https://conductscience.org/api/papers/v1/16039986/cited_by?page=2